MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells

Experimental Biology and Medicine

Volumn 238, Issue 9, 2013, Pages 1024-1032

  Yang, Tao ^a   Zheng, Zhi min ^a   Li, Xiao na ^b   Li, Zhen fu ^a   Wang, Yan ^a   Geng, Yun feng ^a   Bai, Li ^a   Zhang, Xian bo ^a  

^a The First Hospital of Shangjiazhuang City   (China)

^b Hebei Sports Science Research Institute   (China)

Author keywords

ABCB1; Hepatocellular carcinoma; microRNA; miR 223; multidrug resistance; P glycoprotein

Indexed keywords

DOXORUBICIN; ENHANCED GREEN FLUORESCENT PROTEIN; MICRORNA 223; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL;

ARTICLE; BIOINFORMATICS; CELL VIABILITY; CONTROLLED STUDY; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC ANALYSIS; GENETIC REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ABCB1; HEPATOCELLULAR CARCINOMA; MICRORNA; MIR-223; MULTIDRUG RESISTANCE; P-GLYCOPROTEIN;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DOWN-REGULATION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENETIC MARKERS; HUMANS; LIVER NEOPLASMS; MICRORNAS; P-GLYCOPROTEIN;

EID: 84884263684     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213497321     Document Type: Article

References (26)

1. Forner A,Llovet JM,Bruix J.Hepatocellular carcinoma.Lancet. 2012;379:1245-55.
2. Chuu JJ,Liu JM,Tsou MH,Huang CL,Chen CP,Wang HS,Chen CT.Effects of paclitaxel and doxorubicin in histocultures of hepatocelular carcinomas.J Biomed Sci. 2007;14:233-44.
3. Tomimaru Y,Eguchi H,Nagano H,Wada H,Tomokuni A,Kobayashi S,Marubashi S,Takeda Y,Tanemura M,Umeshita K,Doki Y,Mori M.MicroRNA-21 induces resistance to the anti-tumour effect of interferon-alpha/5-fluorouracil in hepatocellular carcinoma cells.Br J Cancer. 2010;103:1617-26.
4. Yeo W,Mok TS,Zee B,Leung TW,Lai PB,Lau WY,Koh J,Mo FK,Yu SC,Chan AT,Hui P,Ma B,Lam KC,Ho WM,Wong HT,Tang A,Johnson PJ.A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.J Natl Cancer Inst. 2005;97:1532-8.
5. Leonard GD,Fojo T,Bates SE.The role of ABC transporters in clinical practice.Oncologist. 2003;8:411-24.
6. Gottesman MM,Ling V.The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research.FEBS Lett. 2006;580:998-1009.
7. Takara K,Sakaeda T,Okumura K.An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy.Curr Pharm Des. 2006;12:273-86.
8. Zhu H,Wu H,Liu X,Evans BR,Medina DJ,Liu CG,Yang JM.Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells.Biochem Pharmacol. 2008;76:582-8.
9. Kurokawa K,Tanahashi T,Iima T,Yamamoto Y,Akaike Y,Nishida K,Masuda K,Kuwano Y,Murakami Y,Fukushima M,Rokutan K.Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells.J Gastroenterol. 2012;47:883-95.
10. Bartel DP.MicroRNAs: genomics, biogenesis, mechanism, and function.Cell. 2004;116:281-97.
11. Ambros V.The functions of animal microRNAs.Nature. 2004;431:350-5.
12. Calin GA,Sevignani C,Dumitru CD,Hyslop T,Noch E,Yendamuri S,Shimizu M,Rattan S,Bullrich F,Negrini M,Croce CM.Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.Proc Natl Acad Sci USA. 2004;101:2999-3004.
13. Chen CZ.MicroRNAs as oncogenes and tumor suppressors.N Engl J Med. 2005;353:1768-71.
14. Friedman RC,Farh KK,Burge CB,Bartel DP.Most mammalian mRNAs are conserved targets of microRNAs.Genome Res. 2009;19:92-105.
15. Liang L,Wong CM,Ying Q,Fan DN,Huang S,Ding J,Yao J,Yan M,Li J,Yao M,Ng IO,He X.MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2.Hepatology (Baltimore, MD). 2010;52:1731-40.
16. Shi W,Gerster K,Alajez NM,Tsang J,Waldron L,Pintilie M,Hui AB,Sykes J,P'ng C,Miller N,McCready D,Fyles A,Liu FF.MicroRNA-301 mediates proliferation and invasion in human breast cancer.Cancer Res. 2011;71:2926-37.
17. Gaziel-Sovran A,Segura MF,Di Micco R,Collins MK,Hanniford D,Vega-Saenz de Miera E,Rakus JF,Dankert JF,Shang S,Kerbel RS,Bhardwaj N,Shao Y,Darvishian F,Zavadil J,Erlebacher A,Mahal LK,Osman I,Hernando E.miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis.Cancer Cell. 2011;20:104-18.
18. Xu K,Liang X,Shen K,Sun L,Cui D,Zhao Y,Tian J,Ni L,Liu J.MiR-222 modulate multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17.Exp Cell Res. 2012;318:2168-77.
19. Yang L,Li N,Wang H,Jia X,Wang X,Luo J.Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance.Oncol Rep. 2012;28:592-600.
20. Chen J,Tian W,Cai H,He H,Deng Y.Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer.Med Oncol (Northwood, London, England). 2012;29:2527-34.
21. Allen KE,Weiss GJ.Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics.Mol Cancer Ther. 2010;9:3126-3136.
22. Wong QW,Lung RW,Law PT,Lai PB,Chan KY,To KF,Wong N.MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.Gastroenterology. 2008;135:257-69.
23. Fazi F,Rosa A,Fatica A,Gelmetti V,De Marchis ML,Nervi C,Bozzoni I.A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis.Cell. 2005;123:819-31.
24. Xu J,Wu C,Che X,Wang L,Yu D,Zhang T,Huang L,Li H,Tan W,Wang C,Lin D.Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.Mol Carcinog. 2011;50:136-42.
25. Cheng SC,Zhou J,Xie Y.P-glycoprotein expression induced by glucose depletion enhanced the chemosensitivity in human hepatocellular carcinoma cell-lines.Cell Biol Int. 2005;29:269-75.
26. Walsh N,Larkin A,Kennedy S,Connolly L,Ballot J,Ooi W,Gullo G,Crown J,Clynes M,O'Driscoll L.Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma.BMC Urol. 2009;9:6-6.